Manchester Central will host the event from 24-28 October 2018, the first time the annual meeting has taken place in the UK.
It follows a successful bid supported by the Christie, the Cancer Research UK Manchester Institute, the University of Manchester, Marketing Manchester and Manchester Central.
Professor Paul Lorigan, leading melanoma oncologist from the Christie said: "It comes as recognition not only of the important work the Christie does in the field of melanoma research, but of also of the global significance of Manchester’s wider scientific community."
The SMR is a volunteer group of scientists working to find the mechanisms responsible for melanoma and new therapies for cancer.
Manchester was chosen as a host because it sets a successful example of collaborative working between clinical and basic research.
Professor Richard Marais of the Cancer Research UK Manchester Institute, based at The University of Manchester, said: "The SMR does some vitally important work to encourage interdisciplinary collaboration and drive forward progress in melanoma research, and it’s very exciting to be welcoming them to Manchester next year. It’s sure to be a stimulating few days."
Amsterdam, Sapporo, Boston, Zurich, and Brisbane have all hosted the congress in previous years.
For more breaking news and in-depth features, sign up to C&IT's daily News Tracker here.